![Uwe Peukert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uwe Peukert
Chief Tech/Sci/R&D Officer at
NewVac LLC
Profile
Dr. Uwe Peukert is SVP-Strategic Investment Initiative at Torrey Pines Investment, Inc. He has over 25 years hands-on experience in the medical field of which he was practicing medicine and medical science for 14 years and he is in his 12th year working within the field of biotechnology and pharmaceutical industry.
Uwe has joined the management team of Torrey Pines Investment, Inc. as a€?SVP Strategic Investment Initiativesa€? and he continues to be the CEO and President of PharmaSearchEval LLC.
He is a highly experienced medical doctor (Board eligible in US for Pediatrics, Neonatology/Intensive Care and Pediatric Cardiology, Board certified in Germany), with a deep scientific foundation (PhD in Pharmacology/Toxicology of Medical School Hannover, Germany).
During the past decade he established a highly successful record of accomplishment in several business development roles serving large and mid-size pharmaceutical companies.
Previously, Dr. Peukert was Senior Director at Onyx Pharmaceuticals where he was responsible for the search and evaluation function within the business development department.
He initiated and lead the technical evaluation/DD resulting in the acquisition of Proteolix Inc (2009, South San Francisco) and the out-licensing of Japanese rights to Carfilzomib to Ono Pharmaceuticals (2010, Osaka/Japan).
Uwe Peukert active positions
| Companies | Position | Start |
|---|---|---|
NewVac LLC
 NewVac LLC Medical/Nursing ServicesHealth Services Develops cancer therapy methods | Chief Tech/Sci/R&D Officer | - |
Former positions of Uwe Peukert
| Companies | Position | End |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | - |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Private Equity Investor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Finance |
NewVac LLC
NewVac LLC Medical/Nursing ServicesHealth Services Develops cancer therapy methods | Health Services |
- Stock Market
- Insiders
- Uwe Peukert
